LGT Group Foundation’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,152
Closed -$235K 305
2025
Q3
$235K Hold
30,152
﹤0.01% 266
2025
Q2
$263K Buy
+30,152
New +$219K ﹤0.01% 263
2024
Q1
Sell
-20,000
Closed -$442K 278
2023
Q4
$442K Hold
20,000
0.01% 215
2023
Q3
$369K Hold
20,000
0.01% 225
2023
Q2
$506K Sell
20,000
-6,600
-25% -$166K 0.01% 230
2023
Q1
$689K Sell
26,600
-18,708
-41% -$501K 0.02% 226
2022
Q4
$1.07M Buy
45,308
+604
+1% +$16.3K 0.03% 217
2022
Q3
$1.13M Buy
44,704
+16,343
+58% +$573K 0.04% 189
2022
Q2
$942K Sell
28,361
-173
-0.6% -$7.35K 0.03% 201
2022
Q1
$2.11M Buy
28,534
+17,184
+151% +$1.24M 0.05% 190
2021
Q4
$1.04M Buy
+11,350
New +$1.36M 0.03% 205

Other funds holding TDOC

LGT Group Foundation's TDOC Position: Q4 2025 in Review

LGT Group Foundation sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 30,152 shares — an estimated $235K sold.

LGT Group Foundation first reported a position in TDOC in Q4 2021 and held it in 11 quarters. The position peaked at $2.11M in Q1 2022. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • LGT Group Foundation reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • LGT Group Foundation sold 30,152 Teladoc Health shares in Q4 2025, an estimated $235K.
  • LGT Group Foundation first reported a position in Teladoc Health in Q4 2021 and held it in 11 quarters.
  • LGT Group Foundation's Teladoc Health position peaked at $2.11M in Q1 2022.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on LGT Group Foundation's 13F filing for Q4 2025, filed 5 Feb 2026.